CN1349802A - Diabetes treating medicine - Google Patents
Diabetes treating medicine Download PDFInfo
- Publication number
- CN1349802A CN1349802A CN 00123115 CN00123115A CN1349802A CN 1349802 A CN1349802 A CN 1349802A CN 00123115 CN00123115 CN 00123115 CN 00123115 A CN00123115 A CN 00123115A CN 1349802 A CN1349802 A CN 1349802A
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- fructus
- diabetes
- pollen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The Chinese medicine with the functions of invigorating qi, mourishing blood, strengthening spleen, nourishing yin, promoting the production of body fluid to quench thirst, raising immunologic function of human body, quickly-reducing blood sugar and glucose in urine for curing diabetes is made up by using 13 Chinese medicinal materials of Chinese yam, dried/fresh rehmannia, anemarrhena root, astragalus root, ophiopogon tuber, trichosanthes root, ginseng and others through the processes of cleaning, drying, sterilizing, mixing secondary sterilizing and filling to obtain the invented product. Its effectual rate is 70% and its effective rate is up to 95.7%.
Description
The present invention relates to a kind of medicine for the treatment of diabetes.
Diabetes are a kind of common incretion metabolism diseases, and except that cancer, cardiovascular and cerebrovascular disease, it is the third-largest killer who jeopardizes people's life at present, are obstinate lifelong participation difficult diseases.The method of Chinese traditional treatment is normally taken Chinese patent medicines such as " diabetes pill ", " more three types of diabetes ", though there is certain curative effect at the clinical practice initial stage, but can only keep symptom, Time of Administration is of a specified duration, curative effect can weaken gradually, to such an extent as to do not reach desired therapeutic effect, use western medicines such as " diamicron ", many untoward reaction can appear in patient: as the individual patients gastrointestinal upset, erythra appears, dosage is crossed conference and hypoglycemic reaction occurred, elderly patients especially, and being associated with ketoacidosis, gestation, liver and kidney failure person in addition all should forbid.As seen can not get good treatment with the Western medicine diabetes, and of long duration, control bad easy generation complication.And the real threat of diabetes is complication.
The object of the present invention is to provide a kind of Chinese medicine preparation for the treatment of diabetes.Its function is YIN nourishing and the production of body fluid promoting, moisturize relieve inflammation or internal heat, blood sugar lowering benefit pancreas.
Medicine of the present invention is to be raw material with Rhizoma Dioscoreae, the Radix Rehmanniae, Fructus Schisandrae Chinensis, Radix Scrophulariae, the Rhizoma Anemarrhenae, the Radix Astragali, Radix Ophiopogonis, pollen, Radix Ginseng, fructus lycii, Cortex cinnamomi japonici (Ramulus Cinnamomi), Fructus Corni, be monarch drug wherein with Rhizoma Dioscoreae, the Radix Rehmanniae, Fructus Schisandrae Chinensis, Radix Scrophulariae are ministerial drug, and assistant is with the Rhizoma Anemarrhenae, the Radix Astragali, Radix Ophiopogonis, pollen, Radix Ginseng, fructus lycii, Cortex cinnamomi japonici (Ramulus Cinnamomi), Fructus Corni.
Each raw materials in part by weight ratio is in the medicine of the present invention:
Rhizoma Dioscoreae 500-700 Radix Rehmanniae 500-700 Radix Scrophulariae 200-400
Radix Astragali 200-400 pollen 200-400 Fructus Schisandrae Chinensis 140-340
Rhizoma Anemarrhenae 140-340 140-340 Radix Ophiopogonis Fructus Corni 140-340
Radix Ginseng 80-280 fructus lycii 80-280 Cortex cinnamomi japonici (Ramulus Cinnamomi) 80-280
The method that above-mentioned each medicine is made medicine is with Rhizoma Dioscoreae, the Radix Rehmanniae, Radix Scrophulariae, the Radix Astragali, pollen, Fructus Schisandrae Chinensis, the Rhizoma Anemarrhenae, Radix Ophiopogonis, Fructus Corni, Radix Ginseng, fructus lycii, Cortex cinnamomi japonici (Ramulus Cinnamomi) after the screening, pulverizes behind rinsing after drying, the ultraviolet disinfection respectively, the packing of sterilizing once more behind the mixing of then each raw material being put together again gets product.
Good effect of the present invention is: Rhizoma Dioscoreae, the Radix Rehmanniae have the effect of nourishing YIN to relieve dryness, nourishing the liver and kidney, can play the effect of benefiting qi and nourishing blood, spleen invigorating yin nourishing, blood sugar lowering benefit pancreas, promoting the production of body fluid to quench thirst behind each crude drug prescription, through clinical verification, I, type ii diabetes people respectively obey 30 minutes ante cibum sooner or later every day 6 (24g) but the body immune function, rapid blood sugar lowering, glucose in urine, to the type i diabetes people that takes insulin through reducing or inactive insulin after 2-3 the course of treatment with this medicine, obvious effective rate reaches 70%, and effective percentage reaches 95.7%.
Embodiment 1: the Rhizoma Dioscoreae 500g after will screening, Radix Rehmanniae 500g, Radix Scrophulariae 200g, Radix Astragali 200g, pollen 200g, Fructus Schisandrae Chinensis 140g, Rhizoma Anemarrhenae 140g, Radix Ophiopogonis 140g, Fructus Corni 140g, Radix Ginseng 80g, fructus lycii 80g, Cortex cinnamomi japonici (Ramulus Cinnamomi) 80g, respectively carry out rinsing, drying, disinfection by ultraviolet light after, pulverize and be 100-120 order medicated powder, sterilization once more behind mixing that each raw material is put together, packing patent medicine.
Embodiment 2: the Rhizoma Dioscoreae 500g after will screening, Radix Rehmanniae 500g, Radix Scrophulariae 200g, Radix Astragali 200g, pollen 200g, Fructus Schisandrae Chinensis 140g, Rhizoma Anemarrhenae 140g, Radix Ophiopogonis 140g, Fructus Corni 140g, Radix Ginseng 80g, fructus lycii 80g, Cortex cinnamomi japonici (Ramulus Cinnamomi) 80g, respectively carry out rinsing, drying, disinfection by ultraviolet light after, pulverize and be 100-120 order medicated powder, sterilization once more behind mixing that each raw material is put together, packing patent medicine.
Embodiment 3 is the optimum weight portion rate: after the Rhizoma Dioscoreae 600g after will screening, Radix Rehmanniae 600g, Radix Scrophulariae 300g, Radix Astragali 300g, pollen 300g, Fructus Schisandrae Chinensis 240g, Rhizoma Anemarrhenae 240g, Radix Ophiopogonis, 240g, Fructus Corni 240g, Radix Ginseng 180g, fructus lycii 180g, Cortex cinnamomi japonici (Ramulus Cinnamomi) 180g, 240g carried out rinsing, drying, disinfection by ultraviolet light respectively, pulverize and be 100-120 order medicated powder, sterilization once more behind mixing that each raw material is put together, packing patent medicine.
Claims (2)
1, a kind of medicine for the treatment of diabetes, it is characterized in that: this raw material and raw materials in part by weight ratio be, Rhizoma Dioscoreae 500-700, Radix Rehmanniae 500-700, Radix Scrophulariae 200-400, Radix Astragali 200-400, pollen 200-400, Fructus Schisandrae Chinensis 140-340, Rhizoma Anemarrhenae 140-340, Radix Ophiopogonis 140-340, Fructus Corni 140-340, Radix Ginseng 80-280, fructus lycii 80-280, Cortex cinnamomi japonici (Ramulus Cinnamomi) 80-280.
2, a kind of manufacture method for the treatment of the medicine of diabetes, it is characterized in that: the Rhizoma Dioscoreae after will screening, the Radix Rehmanniae, Radix Scrophulariae, the Radix Astragali, pollen, Fructus Schisandrae Chinensis, the Rhizoma Anemarrhenae, Radix Ophiopogonis, Fructus Corni, Radix Ginseng, fructus lycii, Cortex cinnamomi japonici (Ramulus Cinnamomi), pulverize the packing patent medicine of sterilizing once more behind the mixing of then each crude drug being put together again respectively behind rinsing after drying, the ultraviolet disinfection.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB001231154A CN100415270C (en) | 2000-10-20 | 2000-10-20 | Diabetes treating medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB001231154A CN100415270C (en) | 2000-10-20 | 2000-10-20 | Diabetes treating medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1349802A true CN1349802A (en) | 2002-05-22 |
| CN100415270C CN100415270C (en) | 2008-09-03 |
Family
ID=4589592
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB001231154A Expired - Fee Related CN100415270C (en) | 2000-10-20 | 2000-10-20 | Diabetes treating medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100415270C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1294847C (en) * | 2005-10-19 | 2007-01-17 | 曲海虎 | Health food for diabetic |
| CN1327881C (en) * | 2005-10-22 | 2007-07-25 | 王万鹏 | Diabetes treating Chinese medicine |
| CN101530565B (en) * | 2009-04-17 | 2011-05-11 | 河北惟祥福中药科技开发有限公司 | Chinese traditional medicine preparation used for curing diabetes and preparation method thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1077642A (en) * | 1993-02-18 | 1993-10-27 | 广东省石龙华南制药厂 | The Chinese prescription of treatment diabetes, preparation and preparation method thereof |
| CN1111522A (en) * | 1995-01-10 | 1995-11-15 | 李仲岭 | Compound islets Langerhans regenerated capsule |
| CN1062154C (en) * | 1996-05-09 | 2001-02-21 | 潘端 | Method for producing Chinese patent medicine for curing diabetes and its pill |
-
2000
- 2000-10-20 CN CNB001231154A patent/CN100415270C/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1294847C (en) * | 2005-10-19 | 2007-01-17 | 曲海虎 | Health food for diabetic |
| CN1327881C (en) * | 2005-10-22 | 2007-07-25 | 王万鹏 | Diabetes treating Chinese medicine |
| CN101530565B (en) * | 2009-04-17 | 2011-05-11 | 河北惟祥福中药科技开发有限公司 | Chinese traditional medicine preparation used for curing diabetes and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100415270C (en) | 2008-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100339123C (en) | Traditional Chinese medicine liquor and preparation method thereof | |
| CN100435831C (en) | Preparation for treating high blood pressure, high blood fat, obesity, and climacteric syndrome, and preparation method | |
| CN101757540A (en) | Traditional Chinese medicine composition for treating nephrotic syndrome and preparation method thereof | |
| CN102119990B (en) | Chinese medicinal capsule for treating femur head necrosis | |
| CN101940694B (en) | Medicament for regulating sub-health of human body | |
| CN104971215A (en) | Traditional Chinese medicine composition for treating spleen-deficiency gastrasthenia type chronic gastritis and preparation method thereof | |
| CN102727779B (en) | Pharmaceutical composition for treating ovarian cysts and preparation method thereof | |
| CN101695527B (en) | Toxin-expelling intestine-moistening Chinese medicinal preparation and preparation method thereof | |
| CN100415270C (en) | Diabetes treating medicine | |
| CN101143205A (en) | Traditional Chinese medicine for treating fever due to qi deficiency | |
| CN103341108B (en) | Pharmaceutical composite for treating stress urinary incontinence after prostatectomy | |
| CN114272344B (en) | Traditional Chinese medicine composition for treating qi-yin deficiency and blood stasis type viscera dysfunction, preparation and application | |
| CN103301372B (en) | Preparation method of umbilicus dressing agent for treating post-operation prostate stress urinary incontinence | |
| CN102824461A (en) | Medicine for treating hypertension and preparation method thereof | |
| CN101966329A (en) | Medicament for treating rash | |
| CN1072940C (en) | Oral liquid for anti-cancer | |
| CN106389738A (en) | Traditional Chinese medicine granules for treating constipation | |
| CN1306830A (en) | Medicine for treating type II diabetes | |
| CN1131029A (en) | Traditional Chinese medicine for curing chronic rhinitis and its preparation method | |
| CN1322879C (en) | Medicine for treating early and medium ankylosing spondylitis | |
| CN1857619A (en) | Chinese medicine preparation for curing diabetes radically | |
| CN105395908A (en) | Application of medicine composition in preparing medicine for treating rheumatic arthritis | |
| CN104547865A (en) | Application of traditional Chinese medicine preparation in preparing medicine for treating senile dementia | |
| CN103007010A (en) | Medicament for treating diabetes | |
| CN1075083A (en) | Treatment vasculitis electuary and its method for making |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080903 Termination date: 20091120 |